AI Analysis AI Analysis of BEAT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BEAT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

BioTelemetry stock upgraded to Sell Candidate
(Updated on Jul 20, 2026)

Sell candidate since Jul 01, 2026 Loss -22.06%

The BioTelemetry stock price gained 1.68% on the last trading day (Monday, 20th Jul 2026), rising from $0.559 to $0.568. During the last trading day the stock fluctuated 7.39% from a day low at $0.544 to a day high of $0.584. The price has fallen in 7 of the last 10 days and is down by -17.74% for this period. Volume fell on the last day by -124 thousand shares and in total, 295 thousand shares were bought and sold for approximately $167.80 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.553 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -31.15% during the next 3 months and, with a 90% probability hold a price between $0.381 and $0.540 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BEAT Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 17, 2026, and so far it has risen 1.68%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioTelemetry stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.587 and $0.717. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BioTelemetry stock

BioTelemetry finds support from accumulated volume at $0.561 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0402 between high and low, or 7.39%. For the last week the stock has had daily average volatility of 14.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BEAT) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect BioTelemetry to open at $0.565, and during the day (based on 14 day Average True Range), to move between $0.537 and $0.600, which gives a possible trading interval of +/-$0.0631 (+/-11.76%) up or down from last closing price. If BioTelemetry takes out the full calculated possible swing range there will be an estimated 11.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.575 (1.20%) than the support at $0.561 (1.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioTelemetry stock A Buy?

BioTelemetry holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.474 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $0.565 ( 0.528%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BEAT Performance

Trading levels for BEAT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.606 6.54%
R2 0.590 3.84%
R1 0.581 2.17%
Price 0.568
S1 0.550 -3.23%
S2 0.541 -4.90%
S3 0.525 -7.60%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.660 16.13%
R2 0.640 12.60%
R1 0.575 1.20%
Price 0.568
S1 0.561 -1.34%
S2 0.559 -1.65%
S3 0 -

FAQ

What is the symbol for BioTelemetry Stock and on which exchange is it traded?
The symbol for BioTelemetry is BEAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioTelemetry Stock?
BioTelemetry holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy BioTelemetry Stock?
BioTelemetry Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioTelemetry Stock.

What's the current price of BioTelemetry Stock?
As of the end of day on the Jul 20, 2026, the price of an BioTelemetry (BEAT) share was $0.568.

What is the 52-week high and low for BioTelemetry Stock?
The 52-week high for BioTelemetry Stock is $4.28 and the 52-week low is $0.509.

What is the market capitalization of BioTelemetry Stock?
As of the Jul 20, 2026, the market capitalization of BioTelemetry is 19.578M.

When is the next earnings date for BioTelemetry?
The upcoming earnings date for BioTelemetry is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOTELEMETRY
BioTelemetry
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
NMRK
$15.02
3.26% Jun 24
JLL
$299.78
8.73% Jun 24
CAG
$13.43
9.20% Jun 23
CBRE
$133.21
4.13% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE